1. Effets cardio-vasculaires des traitements anticholinergiques à visée vésicale chez la personne âgée : une revue
- Author
-
Chesnel, C., Charlanes, A., Hentzen, C., Turmel, N., Biardeau, X., Brochard, C., Campagne, S., Capon, G., Deffieux, X., Fatton, B., Gamé, X., Haddad, R., Jeandel, C., Kerdraon, J., Manceau, P., Mares, P., Mezzadri, M., Mongiat-Artus, P., Petit, A.-C., Peyronnet, B., Soler, J.-M., Thuillier, C., Vetel, J.-M., Robain, G., Amarenco, G., (GRAPPPA), Groupe de recherche appliquée à la pelvi-périnéologie de la personne âgée, CHU Tenon [APHP], Service d'Urologie, andrologie et transplantation rénale [CHRU Lille], Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), CHU Pontchaillou [Rennes], CHU Clermont-Ferrand, service d'urologie [CHU Bordeaux], CHU Bordeaux [Bordeaux], Service de gynécologie-obstétrique, médecine de la reproduction [Béclère], Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Antoine Béclère, Centre Hospitalier Régional Universitaire de Nîmes (CHRU Nîmes), Hôpital de Rangueil, CHU Toulouse [Toulouse], Hôpital Rothschild, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Université de Montpellier (UM), Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de KERPAPE [Ploemeur] (CMRRF), Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape, Service de Neurologie [CHU Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Saint-Antoine [APHP], Service de gynécologie et obstétrique [Hopital Lariboisière - Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Lariboisière-Université Paris Diderot - Paris 7 (UPD7), Service d'Urologie [CHU Saint-Louis], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Centre Bouffard-Vercelli, CHU Grenoble, Centre Hospitalier Le Mans (CH Le Mans), CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Antoine Béclère [Clamart], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Hôpital Rothschild [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), and Université Paris Diderot - Paris 7 (UPD7)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris]
- Subjects
Urinary Bladder, Overactive ,Adverse effects ,Overactive bladder ,Antimuscarinic ,Age Factors ,Effets secondaires ,Muscarinic Antagonists ,Syndrome d’hyperactivité vésicale ,Anticholinergiques ,[SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology ,Système cardiovasculaire ,Cardiovascular system ,Elderly ,Cardiovascular Diseases ,Cholinergic antagonists ,Population gériatrique ,Humans ,Aged - Abstract
International audience; AIM:The aim of this study was to review the evidence regarding the cardiovascular effects of urinary anticholinergic drugs in the elderly.METHODS:A literature review was conducted in October 2017 using the Medline/Pubmed database limiting the search to works in English or French.RESULTS:In total, 602 articles between March 1964 and October 2017 have been reported, 60 studies were analyzed, 19 were prospective trials. Geriatric population has a high prevalence of cardiovascular diseases (24.4% of heart diseases on 65-74years and 36.9% on ≥75years). More than 20% of the geriatric population has overactive bladder history and 41.43% of them use of antimuscarinic drugs. Evaluating the cardiovascular adverse effects of antimusarinics in the geriatric population is not easy because of exclusion of high-risk patients in trials. However, serious cardiovascular adverse effects were reported like atrial fibrillation, atrioventricular block or torsade de pointe. Further studies are needed especially in the "real life" in order to precise the exact prevalence of such cardiovascular alterations.CONCLUSION:Without conclusive evidence, potential cardiovascular adverse effects of anticholinergic agents used in overactive bladder must lead to a cautious prescription.
- Published
- 2018